{"id":4833,"date":"2021-10-05T00:00:00","date_gmt":"2022-10-14T16:14:57","guid":{"rendered":"https:\/\/mdbc1.wpengine.com\/courses\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\/"},"modified":"2023-05-02T08:21:10","modified_gmt":"2023-05-02T12:21:10","slug":"expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update","status":"publish","type":"eb_course","link":"https:\/\/www.mdbriefcase.com\/fr\/courses\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\/","title":{"rendered":"Expert Brief 1: Diabetes Canada Pharmacotherapy of Type 2 Diabetes in Adults \u2013  2020 Update"},"content":{"rendered":"<p>This video helps pharmacists navigate the most recent clinical evidence published by Diabetes Canada for the pharmacologic glycemic management of type 2 diabetes in adults. The goal is to help pharmacists understand the evidence so they can confidently apply it in their practice and help counsel their patients effectively.\n<\/p>\n<hr>\n<p>This program has received an unrestricted educational grant or in-kind support from Abbott, Janssen and Novo Nordisk.<\/p>","protected":false},"featured_media":440667,"comment_status":"open","ping_status":"closed","template":"","eb_course_cat":[],"class_list":["post-4833","eb_course","type-eb_course","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Expert Brief 1: Diabetes Canada Pharmacotherapy of Type 2 Diabetes in Adults \u2013 2020 Update - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Expert Brief 1: Diabetes Canada Pharmacotherapy of Type 2 Diabetes in Adults \u2013 2020 Update - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"This video helps pharmacists navigate the most recent clinical evidence published by Diabetes Canada for the pharmacologic glycemic management of type 2 diabetes in adults. The goal is to help pharmacists understand the evidence so they can confidently apply it in their practice and help counsel their patients effectively. This program has received an unrestricted [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\/\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-02T12:21:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/10\/Diabetes-Pharmacotherapy-EB1-LP-20.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"338\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\\\/\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\\\/\",\"name\":\"Expert Brief 1: Diabetes Canada Pharmacotherapy of Type 2 Diabetes in Adults \u2013 2020 Update - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Diabetes-Pharmacotherapy-EB1-LP-20.jpg\",\"datePublished\":\"2022-10-14T16:14:57+00:00\",\"dateModified\":\"2023-05-02T12:21:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Diabetes-Pharmacotherapy-EB1-LP-20.jpg\",\"contentUrl\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Diabetes-Pharmacotherapy-EB1-LP-20.jpg\",\"width\":600,\"height\":338},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Course\",\"item\":\"https:\\\/\\\/www.mdbriefcase.com\\\/courses\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Expert Brief 1: Diabetes Canada Pharmacotherapy of Type 2 Diabetes in Adults \u2013 2020 Update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#website\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.mdbriefcase.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo.webp\",\"contentUrl\":\"https:\\\/\\\/www.mdbriefcase.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mdbriefcase.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Expert Brief 1: Diabetes Canada Pharmacotherapy of Type 2 Diabetes in Adults \u2013 2020 Update - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/cours\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\/","og_locale":"fr_CA","og_type":"article","og_title":"Expert Brief 1: Diabetes Canada Pharmacotherapy of Type 2 Diabetes in Adults \u2013 2020 Update - MDBriefCase","og_description":"This video helps pharmacists navigate the most recent clinical evidence published by Diabetes Canada for the pharmacologic glycemic management of type 2 diabetes in adults. The goal is to help pharmacists understand the evidence so they can confidently apply it in their practice and help counsel their patients effectively. This program has received an unrestricted [&hellip;]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/cours\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\/","og_site_name":"MDBriefCase","article_modified_time":"2023-05-02T12:21:10+00:00","og_image":[{"width":600,"height":338,"url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/10\/Diabetes-Pharmacotherapy-EB1-LP-20.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/courses\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\/","url":"https:\/\/www.mdbriefcase.com\/courses\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\/","name":"Expert Brief 1: Diabetes Canada Pharmacotherapy of Type 2 Diabetes in Adults \u2013 2020 Update - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\/#primaryimage"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/10\/Diabetes-Pharmacotherapy-EB1-LP-20.jpg","datePublished":"2022-10-14T16:14:57+00:00","dateModified":"2023-05-02T12:21:10+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/courses\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/courses\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\/#primaryimage","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/10\/Diabetes-Pharmacotherapy-EB1-LP-20.jpg","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2021\/10\/Diabetes-Pharmacotherapy-EB1-LP-20.jpg","width":600,"height":338},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/courses\/expert-brief-1-diabetes-canada-pharmacotherapy-of-type-2-diabetes-in-adults-2020-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Course","item":"https:\/\/www.mdbriefcase.com\/courses\/"},{"@type":"ListItem","position":3,"name":"Expert Brief 1: Diabetes Canada Pharmacotherapy of Type 2 Diabetes in Adults \u2013 2020 Update"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/4833","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/eb_course"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=4833"}],"version-history":[{"count":0,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/4833\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media\/440667"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=4833"}],"wp:term":[{"taxonomy":"eb_course_cat","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course_cat?post=4833"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}